Avid Bioservices to Present Two Successful Case Studies Highlighting Development and Manufacturing Expertise That Supports Commercial Production at Upcoming Industry Events Achieved Process Improvements Resulting in a 10X Antibody Production Yield Increase With Product Comparability Supporting a Commercializable Process; Designed and Executed a Comparability Program that Demonstrates Manufacturing Efficiencies and Flexibility Captured by the Transition From a Stainless Steel Process to a Fully Disposable Upstream Process TUSTIN, CA -- (Marketwired) -- 09/11/13 -- Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc., today announced presentations at the following upcoming industry events: ISPE LA Chapter Technology Summit Date: Thursday, September 12, 2013 Time: 9:00am PDT Title: "Process Evolution from the Iron Age to the New Age: A Transition from a Stainless Steel and Glass to a Fully Disposable Upstream Process" Speaker: Michael A. Brown, Associate Scientist, Process Science, Avid Bioservices, Inc. For additional information on the ISPE Technology Summit, please visit: http://www.ispe.org/los-angeles/12-september-event IBC's BioProcess International Conference & Exhibition Date: Wednesday, September 18, 2013 Time: 12:00pm EDT Title: "A Case Study of Multiple Process Improvements Implemented During Clinical Development Resulting in 10X Production Yield with Consistent Product Characteristics" Speakers: Connie Chang, Director, Process Science, Avid Bioservices, Inc. Michael A. Brown, Associate Scientist, Process Science, Avid Bioservices, Inc. In addition, Avid Bioservices will host a booth in the exhibition hall, booth #917. For additional information on IBC's BioProcess International Conference & Exhibition, please visit: http://www.ibclifesciences.com/BPI/overview.xml About Avid Bioservices Avid Bioservices provides a comprehensive range of high quality cGMP manufacturing services for the biotechnology and biopharmaceutical industries to support the manufacture of cGMP clinical phase and commercial products. With over 15 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include GMP clinical and commercial product manufacturing, pur ification, bulk packaging, final product filling, stability testing and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line optimization, cell culture and feed optimization, analytical methods development and product characterization. For more information about Avid, please visit www.avidbio.com. Contact: Chris Keenan or Kelly Pisarev Lord (800) 987-8256 www.avidbio.com
Dollar General Raises Offer for Family Dollar to $80 Per Share in Cash
Avid Bioservices to Present Two Successful Case Studies Highlighting Development and Manufacturing Expertise That Supports
Press spacebar to pause and continue. Press esc to stop.